Cassava Sciences to Hold Corporate Update on November 25th
Cassava Sciences (NASDAQ: SAVA) announced it will host a corporate update via conference call and webcast on Monday, November 25th at 8:00 AM ET. The biotechnology company, which focuses on developing novel Alzheimer's disease treatments, will make the webcast available through their website, with a replay accessible for 90 days following the event on the Company Presentations page.
Cassava Sciences (NASDAQ: SAVA) ha annunciato che ospiterà un aggiornamento aziendale tramite conferenza telefonica e webcast il lunedì 25 novembre alle 08:00 ET. L'azienda biotecnologica, che si concentra sullo sviluppo di nuovi trattamenti per la malattia di Alzheimer, renderà il webcast disponibile attraverso il proprio sito web, e una registrazione potrà essere accessibile per 90 giorni dopo l'evento nella pagina delle Presentazioni Aziendali.
Cassava Sciences (NASDAQ: SAVA) anunció que llevará a cabo una actualización corporativa a través de una llamada de conferencia y transmisión web el lunes 25 de noviembre a las 08:00 AM ET. La empresa biotecnológica, que se centra en desarrollar nuevos tratamientos para la enfermedad de Alzheimer, hará que la transmisión esté disponible a través de su sitio web, con una repetición accesible durante 90 días después del evento en la página de Presentaciones de la Compañía.
카사바 사이언스 (NASDAQ: SAVA)는 11월 25일 월요일 오전 8:00 ET에 전화 회의 및 웹캐스트를 통해 기업 업데이트를 진행할 것이라고 발표했습니다. 알츠하이머병 치료제 개발에 집중하는 생명공학 회사인 카사바는 웹캐스트를 자사 웹사이트를 통해 제공할 예정이며, 이벤트 이후 90일 동안 회사 프레젠테이션 페이지에서 재생이 가능합니다.
Cassava Sciences (NASDAQ: SAVA) a annoncé qu'elle tiendra une mise à jour d'entreprise via une conférence téléphonique et un webinaire le lundi 25 novembre à 8h00 ET. L'entreprise biotechnologique, qui se concentre sur le développement de nouveaux traitements pour la maladie d'Alzheimer, mettra le webinaire à disposition sur son site web, avec une rediffusion accessible pendant 90 jours après l'événement sur la page des Présentations de l'Entreprise.
Cassava Sciences (NASDAQ: SAVA) gab bekannt, dass am Montag, den 25. November um 8:00 Uhr ET ein Unternehmensupdate über eine Telefonkonferenz und Webcast stattfinden wird. Das biotechnologische Unternehmen, das sich auf die Entwicklung neuartiger Behandlungen für die Alzheimer-Krankheit konzentriert, wird den Webcast über seine Website verfügbar machen, mit einer Aufzeichnung, die 90 Tage nach der Veranstaltung auf der Seite Unternehmenspräsentationen zugänglich ist.
- None.
- None.
Webcast planned for Monday, November 25th at 8:00 AM ET
AUSTIN, Texas, Nov. 24, 2024 (GLOBE NEWSWIRE) -- Cassava Sciences, Inc. (NASDAQ: SAVA), a clinical-stage biotechnology company focused on developing a novel treatment for Alzheimer’s disease, today announced it will hold a conference call and webcast on Monday, November 25th at 8:00 a.m. Eastern Time.
| Event Details: | |
| Date: | Monday, November 25th |
| Time: | 8:00 a.m. Eastern Time |
| Webcast: | https://lifescievents.com/event/cassava/ |
A replay of the audio webcast will also be available on the Company Presentations page of the Cassava Sciences website for 90 days following the webcast.
About Cassava Sciences, Inc.
Cassava Sciences is a clinical-stage biotechnology company based in Austin, Texas. Our mission is to detect and treat neurodegenerative diseases, such as Alzheimer’s disease.
Simufilam is an investigational oral, small molecule drug candidate currently being evaluated in two Phase 3 clinical trials for the potential treatment of Alzheimer's disease. Simufilam is a proprietary, investigational oral small molecule that targets the filamin A protein. Cassava Sciences owns exclusive, worldwide rights to its investigational product candidates and related technologies, without royalty obligations to any third party.
For more information, please visit: https://www.CassavaSciences.com
For More Information Contact:
Investors
Sandya von der Weid
svonderweid@lifesciadvisors.com
Media
media@cassavasciences.com
Company
Eric Schoen, Chief Financial Officer
(512) 501-2450
ESchoen@CassavaSciences.com
ir@cassavasciences.com
FAQ
When is Cassava Sciences (SAVA) holding its corporate update webcast?
How long will the replay of SAVA's November 25th webcast be available?
Where can I access Cassava Sciences' (SAVA) November 25th corporate update webcast?
